Dynavax Technologies Corp (NASDAQ: DVAX) is 9.71% higher on its value in year-to-date trading and has touched a low of $9.74 and a high of $14.05 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The DVAX stock was last observed hovering at around $13.88 in the last trading session, with the day’s gains setting it 0.13%.
Currently trading at $14.01, the stock is 5.63% and 8.08% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.19 million and changing 0.94% at the moment leaves the stock 18.01% off its SMA200. DVAX registered 9.80% gain for a year compared to 6-month gain of 24.87%.
The stock witnessed a 8.27% loss in the last 1 month and extending the period to 3 months gives it a 8.94%, and is 2.34% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.02% over the week and 3.14% over the month.
Dynavax Technologies Corp (DVAX) has around 405 employees, a market worth around $1.74B and $277.25M in sales. Current P/E ratio is 80.19 and Fwd P/E is 24.32. Profit margin for the company is 9.85%. Distance from 52-week low is 43.84% and -0.28% from its 52-week high. The company has generated returns on investments over the last 12 months (3.22%).
The EPS is expected to grow by 75.00% this year
The shares outstanding are 125.45M, and float is at 118.57M with Short Float at 16.91%.
The top institutional shareholder in the company is BLACKROCK INC. with over 21.9 million shares valued at $245.97 million. The investor’s holdings represent 16.7308 of the DVAX Shares outstanding. As of 2024-06-30, the second largest holder is DEEP TRACK CAPITAL, LP with 10.9 million shares valued at $122.41 million to account for 8.3259 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 9.37 million shares representing 7.1594 and valued at over $105.26 million, while STATE STREET CORP holds 6.0824 of the shares totaling 7.96 million with a market value of $89.42 million.
Dynavax Technologies Corp (DVAX) Insider Activity
A total of 0 insider transactions have happened at Dynavax Technologies Corp (DVAX) in the last six months, with sales accounting for 0 and purchases happening 0 times. The most recent transaction is an insider sale by CANO FRANCIS, the company’s Director. SEC filings show that CANO FRANCIS sold 3,615 shares of the company’s common stock on May 31 ’24 at a price of $11.93 per share for a total of $43127.0. Following the sale, the insider now owns 36905.0 shares.
Dynavax Technologies Corp (DVAX): Who are the competitors?
One of the company’s main competitors (and peers) include AstraZeneca PLC ADR (AZN) that is trading 19.44% up over the past 12 months.Biogen Inc. (BIIB) lies in the list of competitors of the Dynavax Technologies Corp and is -33.92% lower over the same period from DVAXPfizer Inc. (PFE) is -4.60% down on the 1-year trading charts.
